COVID-19: Vaccine | Testing | Self-assessment | Patient & Visitor Safety | Visitor Policy
Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Details
Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Non-Hodgkins LymphomaStudy Type: InterventionalPhase: IIIStudy Start Date: 02/10/2017Study Completion Date: 07/2022
This is a randomized study to assess the efficacy and safety of the study drug ublituximab and TGR-1202 with or without Bendamustine and then TGR-1202 alone in patients with previously treated Non-Hodgkin’s Lymphoma.
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
View Doctors
Set Your Location
Update
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.